Oral Administration of Artemisinin Analog SM934 Ameliorates Lupus Syndromes in MRL/lpr Mice by Inhibiting Th1 and Th17 Cell Responses | |
Hou, Li-Fei; He, Shi-Jun; Li, Xin; Yang, Yang; He, Pei-Lan; Zhou, Yu; Zhu, Feng-Hua; Yang, Yi-Fu; Li, Ying; Tang, Wei | |
刊名 | ARTHRITIS AND RHEUMATISM
![]() |
2011 | |
卷号 | 63期号:8 |
ISSN号 | 0004-3591 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3678340 |
专题 | 上海中医药大学 |
推荐引用方式 GB/T 7714 | Hou, Li-Fei,He, Shi-Jun,Li, Xin,et al. Oral Administration of Artemisinin Analog SM934 Ameliorates Lupus Syndromes in MRL/lpr Mice by Inhibiting Th1 and Th17 Cell Responses[J]. ARTHRITIS AND RHEUMATISM,2011,63(8). |
APA | Hou, Li-Fei.,He, Shi-Jun.,Li, Xin.,Yang, Yang.,He, Pei-Lan.,...&Zuo, Jian-Ping.(2011).Oral Administration of Artemisinin Analog SM934 Ameliorates Lupus Syndromes in MRL/lpr Mice by Inhibiting Th1 and Th17 Cell Responses.ARTHRITIS AND RHEUMATISM,63(8). |
MLA | Hou, Li-Fei,et al."Oral Administration of Artemisinin Analog SM934 Ameliorates Lupus Syndromes in MRL/lpr Mice by Inhibiting Th1 and Th17 Cell Responses".ARTHRITIS AND RHEUMATISM 63.8(2011). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论